Full Text View
Tabular View
No Study Results Posted
Related Studies
Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism
This study has been completed.
Study NCT00535561   Information provided by Duzce University
First Received: September 25, 2007   No Changes Posted

September 25, 2007
September 25, 2007
June 2007
 
Significant improvement in Hgb and RBC [ Time Frame: 3 months ]
Same as current
No Changes Posted
Significant improvement in serum iron, ferritin, TIBC and possibly in serum TSH and free T4 levels. [ Time Frame: 3 months ]
Same as current
 
Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism
Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism: A Randomized, Double Blinded Study

To determine whether iron deficiency anemia can be an indication for the treatment of subclinical hypothyroidism.

51 Patients presented to our university outpatient internal medicine clinic who are found to have iron deficiency anemia coexisting with subclinical hypothyroidism have been included in this study. Patients were randomly assigned to oral iron or oral iron plus levothyroxin therapy. The physician and the patients did not know who received oral iron only or oral iron plus levthyroine treatment. Hemotologic parameters as well as serum iron, ferritin and iron binding capacity were be measured at the beginning and 3 months after treatment in both groups.

Phase I
Interventional
Treatment, Randomized, Double Blind (Subject, Caregiver, Outcomes Assessor), Parallel Assignment
  • Iron Deficiency Anemia
  • Subclinical Hypothyroidism
  • Drug: Ferrous sulfate
  • Drug: Ferrous sulfate plus levothyroxine
  • Active Comparator: Oral iron treatment only- for iron deficiency anemia and subclinical hypothyroidism coexisting patients
  • Active Comparator: Oral iron plus levothyroine treatment- for iron deficiency anemia and subclinical hypothyroidism coexisting patients

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
September 2007
 

Inclusion Criteria:

  • Clinical diagnosis and laboratory confirmation of iron deficiency anemia and subclinical hypothyroidism
  • Must be able to swallow tablets

Exclusion Criteria:

  • Multifactorial anemia or anemia due to other reasons
  • Iron deficiency anemia requiring urgent intervention- cardiac ischemia, severe anemia,GI or GU losses due to malignancy and or acute/subacute big loses by respiratory, Gİ, GU, etc. system
  • Prior thyroid disorder and/or treatment history
  • Presence of any other co-morbid disease like renal insufficiency/ failure, coronary heart disease, hypertension, diabetes mellitus, any endocrine system disease other than subcli,nical hypothyroidism
Both
23 Years to 73 Years
No
Contact information is only displayed when the study is recruiting subjects
Turkey
 
NCT00535561
 
22-6
Duzce University
 
Study Director: Hakan Cinemre, Assit. Prof. Duzce University School of Medicine
Duzce University
September 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP